Bortezomib enhances expression of effector molecules in anti-tumor CD8+ T lymphocytes by promoting Notch-nuclear factor-κB crosstalk
Menaka C. Thounaojam(Augusta University), Anil Shanker(Meharry Medical College)
Cited by 33
Related Papers
Bortezomib Sustains T Cell Function by Inducing miR-155-Mediated Downregulation of SOCS1 and SHIP1
|Frontiers in Immunology|2021|43